Weekly News Round-Up – 3/4/20
5 years ago
By Josh Neil
With the coronavirus showing no sign of letting up for the next few months at least, we won’t either, bringing you the most up-to-date news on efforts to combat Covid-19 from around the world. This week: Gilead begins remdesivir trials in the UK, health secretary Matt Hancock announces plans to test 100,000 individuals a day shortly, and J&J sign a $1 billion deal with the U.S. government for doses of its in-development vaccine in:
The Round-up Coronavirus Special
(Part 3 of forever)
GILEAD COMMENCES REMDESIVIR TRIALS IN U.K. – Gilead’s antiviral drug remdesivir has commenced testing in the U.K. in a bid to counter Covid-19. The drug is thought to be the best way to treat the coronavirus until a vaccine is created, but is currently unproven. Findings will be seen in the coming weeks.
U.K. HEALTH SECRETARY ANNOUNCES PLANS FOR 100,000 COVID-19 TESTS A DAY – Matt Hancock, the UK’s health secretary, has announced plans to increase coronavirus testing to around 100,000 patients a day as part of a five-part plan to reach the government’s testing target.
JOHNSON & JOHNSON SIGNS $1 BILLION DEAL WITH U.S. GOVERNMENT TO COMBAT COVID – The U.S. government has agreed a $1 billion deal with J&J to procure doses of its in-development vaccine, set to start trials in September 2020 with approval set for 2021. This comes in the same week that Moderna announced a deal with the U.S. Department of Health and Human Services for its vaccine. This will see the government take over manufacture of the candidate so the company can focus further on trials.
In other news:
R&D
Exscientia using AI to screen 15,000 drugs for Covid-19 cure
Clinical Trials
Stem cell therapies show potential for treating Covid-19
Manufacturing
All ranitidine drugs pulled from market over safety concerns
That’s all for now. See you next week!
Joshua Neil, Editor
Proventa International
To ensure you remain up-to-date on the latest in clinical development, sign up for Proventa International’s online Clinical Operations, Supply Chain & Pharmacovigilance Strategy Meeting 2020.
Role of an Immunologist: Exploring the Responsibilities
In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...
2 years agoRole of an Immunologist: Exploring the Responsibilities
In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...
2 years ago
Improving Warehouse Efficiency: The Role of Technology and Best Practices
In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...
2 years agoImproving Warehouse Efficiency: The Role of Technology and Best Practices
In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...
2 years ago
How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency
Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...
2 years agoHow to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency
Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...
2 years ago